UB Paderborn / Katalog / Suche / in CDI

1 – 15 von 15

Sortiert nach

Impact of Comorbidities on Tumor Necrosis Factor Inhibitor Therapy in Psoriatic Arthritis: A Population‐Based Cohort Study

Arthritis care & research (2010), 2018-04, Vol.70 (4), p.592-599

2018

Link zum Volltext

Verfügbarkeit prüfen

Drug survival of biologics and novel immunomodulators for rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, and psoriasis - A nationwide cohort study from the DANBIO and DERMBIO registries

Seminars in arthritis and rheumatism, 2022-04, Vol.53, p.151979-151979, Article 151979

2022

Link zum Volltext

Verfügbarkeit prüfen

Effect of a 12-week high-intensity exercise intervention: a comparison of cardiac exercise adaptations during biological disease-modifying antirheumatic drug treatment (TNF inhibitors vs IL-6 signalling inhibitors) in patients with rheumatoid arthritis – study protocol for a randomised controlled trial

BMJ open, 2023-05, Vol.13 (5), p.e068600-e068600

2023

Link zum Volltext

Verfügbarkeit prüfen

PsAID12 Provisionally Endorsed at OMERACT 2018 as Core Outcome Measure to Assess Psoriatic Arthritis-specific Health-related Quality of Life in Clinical Trials

Journal of rheumatology, 2019-08, Vol.46 (8), p.990

2019

Link zum Volltext

Verfügbarkeit prüfen

A systematic review of measurement properties of patient reported outcome measures in psoriatic arthritis: A GRAPPA-OMERACT initiative

Seminars in arthritis and rheumatism, 2018-04, Vol.47 (5), p.654-665

2018

Link zum Volltext

Verfügbarkeit prüfen

Cardiac arrest in anti-mitochondrial antibody associated inflammatory myopathy

Oxford Medical Case Reports, 2021-03, Vol.2021 (3), p.omaa150

2021

Link zum Volltext

Verfügbarkeit prüfen

Content and Face Validity and Feasibility of 5 Candidate Instruments for Psoriatic Arthritis Randomized Controlled Trials: The PsA OMERACT Core Set Workshop at the GRAPPA 2017 Annual Meeting

Journal of rheumatology. Supplement, 2018-06, Vol.94, p.17

2018

Link zum Volltext

Verfügbarkeit prüfen

Antibodies to Infliximab and Adalimumab in Patients with Rheumatoid Arthritis in Clinical Remission: A Cross-Sectional Study

Arthritis, 2015-01, Vol.2015, p.784825-7

2015

Link zum Volltext

Verfügbarkeit prüfen

Evidence for Psoriatic Arthritis Impact of Disease (PsAID12) as Core Instrument to Measure Health-Related Quality of Life in Psoriatic Arthritis: A Systematic Review of Psychometric Properties

Journal of psoriasis and psoriatic arthritis, 2020-01, Vol.5 (1), p.12-22

2020

Link zum Volltext

Verfügbarkeit prüfen

Association between tobacco smoking and response to tumour necrosis factor [alpha] inhibitor treatment in psoriatic arthritis: results from the DANBIO registry

Annals of the rheumatic diseases, 2015-12, Vol.74 (12), p.2130

2015

Link zum Volltext

Verfügbarkeit prüfen

Test-retest Reliability for HAQ-DI and SF-36 PF for the Measurement of Physical Function in Psoriatic Arthritis

Journal of rheumatology, 2021-10, Vol.48 (10), p.1547

2021

Link zum Volltext

Verfügbarkeit prüfen

OMERACT Filter 2.1 instrument selection for physical function domain in psoriatic arthritis: Provisional endorsement for HAQ-DI and SF-36 PF

Seminars in arthritis and rheumatism, 2021-10, Vol.51 (5), p.1117-1124

2021

Link zum Volltext

Verfügbarkeit prüfen

Clinical trial discrimination of physical function instruments for psoriatic arthritis: A systematic review

Seminars in arthritis and rheumatism, 2020-10, Vol.50 (5), p.1158-1181

2020

Link zum Volltext

Verfügbarkeit prüfen

Mechanical cardiac massage

Ugeskrift for læger, 2009-08, Vol.171 (35), p.2463

2009

Link zum Volltext

Verfügbarkeit prüfen

Cardiac arrest in anti-mitochondrial antibody associated inflammatory myopathy

Oxford medical case reports, 2021, Vol.2021 (3), p.omaa150-omaa150

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 15 von 15

Suche als RSS-Feed

Aktive Filter

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(13)
Mit Volltextzugriff
(11)

Publikationsform

Artikel
(14)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(11)
Science & Technology
(11)
Rheumatology
(10)
Humans
(8)
Psoriatic Arthritis
(8)
Antirheumatic Agents - Therapeutic Use
(4)
Arthritis, Psoriatic - Diagnosis
(4)
Arthritis, Psoriatic - Drug Therapy
(3)
Psoriasis
(3)
Quality Of Life
(3)
Reproducibility Of Results
(3)
Rheumatoid Arthritis
(3)
Tumor Necrosis Factor-Tnf
(3)
Arthritis
(2)
Arthritis, Rheumatoid - Drug Therapy
(2)
Core Set
(2)
Disease
(2)
General & Internal Medicine
(2)
Grappa
(2)
Health Risk Assessment
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Impact of Comorbidities on Tumor Necrosis Factor Inhibitor Therapy in Psoriatic Arthritis: A Population‐Based Cohort Study

Drug survival of biologics and novel immunomodulators for rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, and psoriasis - A nationwide cohort study from the DANBIO and DERMBIO registries

PsAID12 Provisionally Endorsed at OMERACT 2018 as Core Outcome Measure to Assess Psoriatic Arthritis-specific Health-related Quality of Life in Clinical Trials

A systematic review of measurement properties of patient reported outcome measures in psoriatic arthritis: A GRAPPA-OMERACT initiative

Cardiac arrest in anti-mitochondrial antibody associated inflammatory myopathy

Content and Face Validity and Feasibility of 5 Candidate Instruments for Psoriatic Arthritis Randomized Controlled Trials: The PsA OMERACT Core Set Workshop at the GRAPPA 2017 Annual Meeting

Antibodies to Infliximab and Adalimumab in Patients with Rheumatoid Arthritis in Clinical Remission: A Cross-Sectional Study

Evidence for Psoriatic Arthritis Impact of Disease (PsAID12) as Core Instrument to Measure Health-Related Quality of Life in Psoriatic Arthritis: A Systematic Review of Psychometric Properties

Association between tobacco smoking and response to tumour necrosis factor [alpha] inhibitor treatment in psoriatic arthritis: results from the DANBIO registry

Test-retest Reliability for HAQ-DI and SF-36 PF for the Measurement of Physical Function in Psoriatic Arthritis

OMERACT Filter 2.1 instrument selection for physical function domain in psoriatic arthritis: Provisional endorsement for HAQ-DI and SF-36 PF

Clinical trial discrimination of physical function instruments for psoriatic arthritis: A systematic review

Mechanical cardiac massage

Cardiac arrest in anti-mitochondrial antibody associated inflammatory myopathy

Aktive Filter

Suchergebnisse filtern